Although the latest economic forecasts for Asia, the US and Europe have increased growth estimates for next year, analytical instrument and laboratory product company executives are a bit less sanguine, but positive overall, according to the results of IBO’s latest Fall Business Climate Survey. Signs of recovery abound worldwide, though caution runs high due to […]
Despite extreme market volatility, the Dow Jones Industrial Average, S&P 500 and NASDAQ ended the month up 2.3%, 3.6% and 5.6%, respectively. For most of September, the US equity markets were bolstered by the declining US dollar and optimistic statements by the Federal Reserve. In addition, several economic indicators for August, such as industrial production, […]
Second-quarter 2009 IBO Life Science Index sales declined 4.3% to $2,336.48 million. Operating profit grew 5.9% to $404.34 million, and operating margin climbed 170 basis points to 17.3% of sales. Sales growth for a majority of companies was adversely affected by currency transactions and budget constraints. Operating profits benefited from restructuring activities. Second-quarter sales for […]
In August, US equity markets experienced broad gains driven by positive economic data and government spending. The Dow Jones Industrial Average, S&P 500 and NASDAQ ended the month up 3.5%, 3.4% and 1.5%, respectively. Economists projected a 2% GDP growth for the US for the third quarter. The Commerce Department revised the US second-quarter GDP […]
Compared to the first quarter of the calendar year, little changed in the second quarter for a number of major, publicly held analytical instrument and laboratory product companies. However, several companies indicated that they believed the worst effects of the recession were over. In fact, many companies reported sequential improvements in either orders or sales […]
In the second quarter of 2009, revenues for IBO’s Laboratory Sales Index fell 7.8% to $4,285.24 million. Operating profit slipped 1.0% to $746.27 million, but operating margin gained 120 basis points to 17.4% of sales. Revenue growth for a majority of the companies in the Index was negatively impacted by currency translation and reduced capital […]
Perhaps the most enthralling display of fireworks in July was seen on Wall Street as the equity markets exploded on the upside. The Dow Jones Industrial Average, S&P 500 and NASDAQ ended the month up 8.6%, 7.4% and 7.8%, respectively. The sharp rise was ignited by earnings optimism as Goldman Sachs and Intel announced better […]
One of the enduring features of the analytical and life science instrument industry is its steadfastness. Although sales ebb and flow based on changes in applications and market requirements, they seldom exhibit significant year-to-year fluctuations. Unfortunately, 2009 appears to be a glaring exception. In January, when the 2009 IBO forecast issue was researched and published […]
Two companies in IBO’s Laboratory Instrument Sales Index reported fiscal year-end March 31 results after the publication of the 2008 and first-quarter Index numbers (see IBO 2/15/09, 4/30/09, 5/15/09). Including year-end results for Shimadzu and Oxford Instruments (Analytical), Index revenues rose 12.1% in 2008 and operating profits increased 14.5%. For the first quarter, Index sales […]
First-quarter revenues for the IBO Lab Equipment/Consumables Index declined 9.9% to $803.18 million and operating profits fell 9.8% to $245.35 million, while operating margin was unchanged at 30.5% of sales. Unfavorable currency transactions for US companies and reduced R&D spending by customers resulted in lower revenue growth. Biohit Oyj’s first-quarter sales grew 2.0% to €8.3 […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
